Research

Data Sharing

Project MinE promotes broad, transparant and responsible data sharing.

The resource is available to all bona fide researchers for all types of health-related research that is in the public interest, without preferential or exclusive access for any person.

If you have novel proposals with individual level data either genotype or whole genome sequencing (WGS), please fill in the form for GWAS data (see form below) or for WGS (Data Request Form WGS and email to info@projectmine.com)

All researchers, whether in universities, charities, government agencies or commercial companies*, will be subject to the same application process and approval criteria:

  1. Your research request will be evaluated by the Project MinE staff and circulated among the data access committee for approval
  2. If positive, you and your fellow investigators will receive a data access agreement to be signed
  3. You will be granted access to the data using a suitable method
  4. At publication add suitable acknowledgement (Project MinE publication policy)

*data access for commercial companies is limited

GWAS Data Request Form

A. Contact Details

Indicate your contact details.

This field is required. This field is required. This field is required. This field is required.

B. Specify dataset requested

Cohort Total Cases Controls Males Females Country Platform Reference
BE1 682 311 371 351 331 Belgium 370K v. Es, Nat Genet, 2008
BE2 475 225 250 272 203 Belgium OmniExpress -
CZ1 464 228 236 269 195 Switzerland OmniExpress -
FIN4 144 144 0 73 71 Finland OmniExpress
FR1 975 251 724 836 139 France 317K Landers, PNAS, 2009
FR3 363 363 0 193 170 France OmniExpress -
GER2 866 580 286 523 343 Germany OmniExpress -
IR1 432 221 211 231 201 Ireland 550K Cronin, Hum Mol Genet, 2008
IR2 230 103 127 109 121 Ireland 610K v. Es, Nat Genet, 2009
IR3 746 268 478 417 329 Ireland OmniExpress -
IT1 141 141 0 Italy 610K Traynor, PNAS, 2010
IT2 507 261 246 Italy 550K Chio, Hum Mol Genet, 2009
IT4 411 311 100 219 192 Italy OmniExpress -
NL1 911 461 450 540 371 Netherlands 317K v. Es, Lancet Neurol, 2007
NL1 911 461 450 NL 317K v. Es, Lancet Neurol, 2007
NL2 1211 582 629 718 493 Netherlands 370K v. Es, Nat Genet, 2008
NL4 3488 1226 2262 1998 1490 Netherlands OmniExpress -
NL5 1316 697 619 772 544 Netherlands 2.5M -
PU1 94 40 54 53 41 Portugal OmniExpress -
SP1 168 105 63 89 79 Spain OmniExpress -
SW1 993 493 500 554 439 Sweden 370K v. Es, Nat Genet, 2008
SW2 552 281 271 287 265 Sweden OmniExpress -
UK1 466 245 221 285 181 UK 317K Landers, PNAS, 2009
UK2 661 661 0 423 238 UK 550K Shatunov, Lancet Neurol, 2009
UK5 1228 1214 14 728 500 UK OmniExpress
US1 1564 753 811 975 589 USA 317K Landers, PNAS, 2009
US2 527 0 527 USA 550K Traynor, PNAS,2010
US6 107 65 42 56 51 USA OmniExpress -
US7 573 573 0 339 234 USA OmniExpress -

C. Research Question, Goal, or Specific Aims

Provide a brief description (e.g., 1 paragraph) describing the aims of the proposal and the research questions to be addressed.

This field is required.

D. Analytic Plan

Provide a brief description of the analyses to be performed to address the research questions described above. Include relevant details e.g. phenotype definition, QC, analysis, plans to address population stratification and other co-founder, power.

This field is required.

E. Data Usage Policy